ATOSSA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $3.1M | $3.0M |
| FY2017 | — | $6.9M | $7.2M |
| FY2018 | — | $8.8M | $10.4M |
| FY2019 | — | $13.2M | $12.6M |
| FY2020 | — | $27.2M | $39.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $3.1M | $3.0M |
| FY2017 | — | $6.9M | $7.2M |
| FY2018 | — | $8.8M | $10.4M |
| FY2019 | — | $13.2M | $12.6M |
| FY2020 | — | $27.2M | $39.6M |